SHARED: FDA issues warning letter for not including the most serious risks in advertisement for medication-assisted treatment drug — NationalAddictionNews.com

The U.S. Food and Drug Administration today posted a warning letter to Alkermes, Inc. of Massachusetts, for inaccurately branding the drug Vivitrol (an extended-release injection formulation of naltrexone) by omitting warnings about the most serious risks associated with the drug from promotional materials. Vivitrol is approved for the prevention of relapse to opioid dependence, following … Continue reading SHARED: FDA issues warning letter for not including the most serious risks in advertisement for medication-assisted treatment drug — NationalAddictionNews.com

NEWS FEED: In The Latest War On Opioid Addiction, The FDA Green-lights Generic Film Strip Of Addiction Drug Suboxone

The generic drug will most likely be less expensive, and this could make it more widely available to those who couldn’t previously afford it. On Thursday, the U.S. Food and Drug Administration ... Source: In The Latest War On Opioid Addiction, The FDA Green-lights Generic Film Strip Of Addiction Drug Suboxone